Hyphens Pharma: General Announcement-RESULTS BRIEFING 1H 2022
Hyphens Pharma: Financial Statements and Related Announcement-Half Yearly Results
Hyphens Pharma: General Announcement-COMPLETION OF INVESTMENT IN DOCMED TECHNOLOGY
Hyphens Pharma: Annual Reports and Related Documents
Hyphens Pharma: General Announcement-CORPORATE PRESENTATION - DOCMED
Hyphens Pharma: General Announcement-HYPHENS ATTRACTS S$6 MILLION INVESTMENT IN DOCMED TECHNOLOGY TO GROW DIGITAL HEALTHTECH
Hyphens Pharma: General Announcement-Quarterly Business Update For the First Quarter Ended 31 March 2022
Hyphens Pharma: Change - Announcement of Cessation-Resignation of Chief Financial Officer
Hyphens Pharma: REPL-Annual General Meeting-Voluntary
Hyphens Pharma: REPL-Annual General Meeting-Voluntary
Hyphens Pharma: Cash Dividend/ Distribution-Mandatory
Hyphens Pharma: Annual General Meeting-Voluntary
Hyphens Pharma: Annual Reports and Related Documents
Hyphens Pharma: General Announcement-RESULTS BRIEFING FY2021
Hyphens Pharma: Financial Statements and Related Announcement-Full Yearly Results
Hyphens Pharma: General Announcement-CORPORATE PRESENTATION
Hyphens Pharma: General Announcement-HYPHENS PHARMA OFFICIALLY LAUNCHES WELLAWAY
Hyphens Pharma: General Announcement-HYPHENS PHARMA HAS INKED EXCLUSIVE LICENSING DEAL OF USTEKINUMAB BIOSIMILAR
Hyphens Pharma: Asset Acquisitions and Disposals-STRIKING-OFF OF INDIRECT WHOLLY-OWNED SUBSIDIARY, DAC PHARMALAB PTE LTD
Hyphens Pharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-CHANGE OF DIRECTOR'S INTEREST - MR TAN CHWEE CHOON
No Data
No Data